Published in:
01-12-2013 | Erratum
Erratum to: Identification of differentially expressed proteins in chemotherapy-sensitive and chemotherapy-resistant diffuse large B cell lymphoma by proteomic methods
Published in: Medical Oncology | Issue 4/2013
Login to get accessExcerpt
Unfortunately, there is an error in the second author affiliation and Table 3 of the original publication. It has been corrected with this erratum.
Table 3
Immunohistochemical detection of glutathione S-transferase (GSTP1), heat shock protein beta-1 (HSPB1), ezrin (EZR), and pleckstrin (PLEK) expression in low sensitivity and high sensitivity groups of diffuse large B cell lymphoma tissues
|
GSTP1
|
HSPB1
|
EZR
|
PLEK
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Positive
|
Negative
|
p
|
Positive
|
Negative
|
p
|
Positive
|
Negative
|
p
|
Positive
|
Negative
|
p
|
|
|
Low sensitivity (relapse or PD)
|
35
|
7
|
<0.01
|
38
|
4
|
<0.01
|
11
|
31
|
<0.01
|
9
|
33
|
<0.01
|
|
High sensitivity (CR or PR)
|
12
|
44
|
14
|
42
|
48
|
8
|
45
|
11
|
||||
1.
The full affiliation of the second author “Liang Zeng” should be “Department of Pathology, Tumor Hospital Xiangya School of Medicine of Central South University, Changsha 410008, People’s Republic of China.”
2.
In Table 3, the outcome in the parentheses following low sensitivity should be “(relapse or PD)” and that following high sensitivity should be “(CR or PR)”. The revised table is presented below.